Metabolic syndrome in patients with psoriasis: A comparative study
Background: Psoriasis patients are at increased risk of developing the metabolic syndrome (MS). Proinflammatory cytokines such as tumor necrosis factor-α, interleukin-6 that are increased in the psoriatic plaques are known to contribute to features of MS such as hypertension, dyslipidemia and insuli...
Main Authors: | Sristi Lakshmi, Amiya Kumar Nath, Carounanidy Udayashankar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Indian Dermatology Online Journal |
Subjects: | |
Online Access: | http://www.idoj.in/article.asp?issn=2229-5178;year=2014;volume=5;issue=2;spage=132;epage=137;aulast=Lakshmi |
Similar Items
-
Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris
by: Drahomira Holmannova, et al.
Published: (2020-08-01) -
Presence of selected metabolic syndrome components in patients with psoriasis vulgaris
by: Sebastian Uczniak, et al.
Published: (2016-05-01) -
Interleukin-17 levels in patients with psoriasis with or without metabolic syndrome
by: Hanan Morsy, et al.
Published: (2019-01-01) -
Features of treatment of patients with psoriasis with metabolic syndrome
by: V. R. Khairutdinov, et al.
Published: (2018-12-01) -
Effects of psoriasis and metabolic syndrome on male sexual functions
by: Hüseyin Saygın, et al.
Published: (2021-07-01)